CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026

ConferenceFAI-ScorePositive
AI Analysis

Summary

Caristo Diagnostics will present findings on its coronary inflammation and plaque analysis technologies at SCCT 2026, with three of six Young Investigator Award-nominated abstracts utilizing the company's technologies, including a new application of FAI-Score on non-contrast cardiac CT.

Importance:3/10
Sentiment:
0.40
conference presentationdiagnostic technologycardiac imagingresearch recognitionaward nomination
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on July 8, 2026 11:21 AM

Read Original